Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (4) , 721-728
- https://doi.org/10.1016/s0002-8703(03)00163-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Metoprolol controlled release/extended release in patients with severe heart failureJournal of the American College of Cardiology, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Effect of Metoprolol on the Prognosis for Patients With Suspected Acute Myocardial Infarction and Indirect Signs of Congestive Heart Failure (A Subgroup Analysis of the Göteborg Metoprolol Trial)The American Journal of Cardiology, 1997
- Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trialsEuropean Heart Journal, 1992
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981